Janice Morrison
Adult Health · Palm Beach Gardens, FLNPI 1033599170
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 6 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 3 manufacturers reported payments, led by Amarin Pharma, Inc. at 39.5% of the total. 2025 is the largest year on record at $228, 5.7 times the $40 reported in 2023. That places this record below the midpoint for adult health clinicians in FL, where the typical reported total is $505.
Across 6 payments — averaging $51.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amarin Pharma, Inc.$122
- Viatris Specialty LLC$106
- Mylan Specialty L.p.$80
What the payments were for
- Food & beverage$308100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amarin Pharma, Inc. | 1 | $122 |
| Viatris Specialty LLC | 1 | $106 |
| Mylan Specialty L.p. | 4 | $80 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$308 in reported general payments places this provider in the 40th percentile of 2,237 adult health providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 59 | $32,167 |
| Lacosamide | 30 | $5,404 |
| JanuviaSitagliptin Phosphate | 16 | $4,564 |
| Tresiba Flextouch U-200Insulin Degludec | 15 | $4,035 |
| Clonidine | 25 | $3,943 |
| Colesevelam Hcl | 12 | $3,360 |
| Mirtazapine | 80 | $2,999 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 31 | $2,955 |
| Methenamine Hippurate | 35 | $2,774 |
| Pantoprazole Sodium | 122 | $2,478 |
| Pregabalin | 82 | $2,086 |
| Midodrine Hcl | 25 | $1,948 |
| Mesalamine ErMesalamine | 12 | $1,635 |
| Trazodone Hcl | 94 | $1,562 |
| Gabapentin | 58 | $1,389 |
Paid to pharmacies, not to this prescriber.
Other adult health in Palm Beach Gardens
- Patricia PagnottaMaitland$409K
- Carly KoelschSarasota$265K
- Norma SolisMiami$150K
- Ashley PontenbergWinter Park$136K
- Jeffrey HernandezMiami$122K
- Jamie JohnsonTampa$58K
- Jessica MangesClearwater$52K
- Sita SwamyOrlando$49K
- Cynthia OteroMaitland$31K
- Jennifer GodshallTampa$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.